The introduction of nicotinamide as a nicotine replacement in e-cigarette and smokeless goods represents a big regulatory challenge to the FDA. Nicotinamide doesn't have nicotinic receptor agonist exercise and is known to work as a sedative at substantial dosages6. The claims created by Nicotine